- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| So | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| Fr | AUSTRALIAN CLINICAL LABS LIMITED: Notification of cessation of securities - ACL | - | ASX | ||
| Do | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| Mi | AUSTRALIAN CLINICAL LABS LIMITED: Ceasing to be a substantial holder | 1 | ASX | ||
| 24.02. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| AUSTRALIAN CLINICAL LABS Aktie jetzt für 0€ handeln | |||||
| 24.02. | AUSTRALIAN CLINICAL LABS LIMITED: Becoming a substantial holder | - | ASX | ||
| 23.02. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 22.02. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | 1 | ASX | ||
| 20.02. | AUSTRALIAN CLINICAL LABS LIMITED: Change of Director's Interest Notice - S Butler | - | ASX | ||
| 19.02. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 18.02. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 17.02. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 16.02. | Why Audinate, Australian Clinical Labs, Coronado, and Treasury Wine shares are sinking today | 1 | The Motley Fool Australia | ||
| 16.02. | Australian Clinical Labs shares hit record low as CEO to exit | 1 | The Motley Fool Australia | ||
| 15.02. | AUSTRALIAN CLINICAL LABS LIMITED: CEO contract update | - | ASX | ||
| 15.02. | AUSTRALIAN CLINICAL LABS LIMITED: Dividend/Distribution - ACL | - | ASX | ||
| 15.02. | AUSTRALIAN CLINICAL LABS LIMITED: ACL 1H26 financial results investor presentation | - | ASX | ||
| 15.02. | AUSTRALIAN CLINICAL LABS LIMITED: Appendix 4D and 1H26 financial reports | - | ASX | ||
| 29.01. | AUSTRALIAN CLINICAL LABS LIMITED: 1H26 results - investor webinar | - | ASX |
1 2 3 4 5 Weiter >>
92 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 25,800 | -4,87 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,110 | -2,01 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| MEDTRONIC | 83,94 | +0,05 % | Medtronic Launches MiniMed Go Smart MDI System In Europe | WASHINGTON (dpa-AFX) - Medtronic (MDT) announced the commercial launch in Europe of the MiniMed Go Smart MDI system with the Simplera sensor. The launch will be rolled out gradually across Europe... ► Artikel lesen | |
| STRATEC | 20,650 | -2,13 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| M1 KLINIKEN | 16,800 | -2,55 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| ZIMMER BIOMET | 84,36 | -0,89 % | Former Zimmer Biomet leader Kraal to head up Baxter Connected Care | ||
| RYMAN HEALTHCARE | 1,175 | -3,61 % | RYMAN HEALTHCARE LIMITED: SPH Notice - Cooper Investors Pty Limited | ||
| SONIC HEALTHCARE | 14,626 | +1,06 % | Laufende Fusionskontrollverfahren: Sonic Healthcare Limited, Sydney /Australien; Erwerb eines Mehrheitsanteils an und alleiniger Kontrolle über die Medizinisches Versorgungszentrum Labor Dr. Klein Dr. Schmitt GmbH, Kaiserslautern | Datum der Anmeldung:31.10.2025Aktenzeichen:B3-103/25Unternehmen:Sonic Healthcare Limited, Sydney/Australien; Erwerb eines Mehrheitsanteils an und alleiniger Kontrolle über die Medizinisches Versorgungszentrum... ► Artikel lesen | |
| AMBU | 10,640 | +0,57 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| TRANSMEDICS GROUP | 125,65 | 0,00 % | TransMedics Group, Inc.: TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results | ANDOVER, Mass., Feb. 24, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant... ► Artikel lesen | |
| CVS | 14,700 | 0,00 % | CVS Group plc - Total Voting Rights | ||
| EMBLA MEDICAL | 3,950 | +1,80 % | EMBLA MEDICAL HF: Transactions in relation to Share Buyback Program | ||
| EUROEYES | - | - | EUROEYES (01846): (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO THE ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF FYEO EUROPE B.V.; AND (2) RESUMPTION ... | ||
| HEALIUS | 0,388 | 0,00 % | HEALIUS LIMITED: Change in substantial holding | ||
| SIEMENS HEALTHINEERS | 41,370 | -1,83 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen |
AUSTRALIAN CLINICAL LABS LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AUSTRALIAN CLINICAL LABS LIMITED finden Sie auf Wallstreet Online.